LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 126

Search options

  1. Article ; Online: N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial.

    Wolfsegger, Thomas / Böck, Klaus / Schimetta, Wolfgang / von Oertzen, Tim J / Assar, Hamid

    Neurological research and practice

    2021  Volume 3, Issue 1, Page(s) 29

    Abstract: Oral administration of N,N-Dimethylglycine (DMG), a tertiary amino acid, presumably enhances oxygen ...

    Abstract Oral administration of N,N-Dimethylglycine (DMG), a tertiary amino acid, presumably enhances oxygen utilization by tissue and complex with free radicals. Beneficial effects are improved endurance performance and reduction fatigue in humans and animals. This pilot study reports the results over a one-year double-blind, placebo-controlled trial of DMG in 30 randomized patients with progressive multiple sclerosis. No treatment effects were found between the placebo group and the DMG group for disability, fatigue, cognitive, or gait parameters.
    Language English
    Publishing date 2021-05-24
    Publishing country England
    Document type Letter
    ISSN 2524-3489
    ISSN (online) 2524-3489
    DOI 10.1186/s42466-021-00126-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Metabolism of vertebrate amino sugars with N-glycolyl groups: resistance of α2-8-linked N-glycolylneuraminic acid to enzymatic cleavage.

    Davies, Leela R L / Pearce, Oliver M T / Tessier, Matthew B / Assar, Siavash / Smutova, Victoria / Pajunen, Maria / Sumida, Mizuki / Sato, Chihiro / Kitajima, Ken / Finne, Jukka / Gagneux, Pascal / Pshezhetsky, Alexey / Woods, Robert / Varki, Ajit

    The Journal of biological chemistry

    2012  Volume 287, Issue 34, Page(s) 28917–28931

    Abstract: The sialic acid (Sia) N-acetylneuraminic acid (Neu5Ac) and its hydroxylated derivative N ... may partly explain reduced enzymatic activity. In keeping with this, polymers of N-propionylneuraminic ...

    Abstract The sialic acid (Sia) N-acetylneuraminic acid (Neu5Ac) and its hydroxylated derivative N-glycolylneuraminic acid (Neu5Gc) differ by one oxygen atom. CMP-Neu5Gc is synthesized from CMP-Neu5Ac, with Neu5Gc representing a highly variable fraction of total Sias in various tissues and among different species. The exception may be the brain, where Neu5Ac is abundant and Neu5Gc is reported to be rare. Here, we confirm this unusual pattern and its evolutionary conservation in additional samples from various species, concluding that brain Neu5Gc expression has been maintained at extremely low levels over hundreds of millions of years of vertebrate evolution. Most explanations for this pattern do not require maintaining neural Neu5Gc at such low levels. We hypothesized that resistance of α2-8-linked Neu5Gc to vertebrate sialidases is the detrimental effect requiring the relative absence of Neu5Gc from brain. This linkage is prominent in polysialic acid (polySia), a molecule with critical roles in vertebrate neural development. We show that Neu5Gc is incorporated into neural polySia and does not cause in vitro toxicity. Synthetic polymers of Neu5Ac and Neu5Gc showed that mammalian and bacterial sialidases are much less able to hydrolyze α2-8-linked Neu5Gc at the nonreducing terminus. Notably, this difference was not seen with acid-catalyzed hydrolysis of polySias. Molecular dynamics modeling indicates that differences in the three-dimensional conformation of terminal saccharides may partly explain reduced enzymatic activity. In keeping with this, polymers of N-propionylneuraminic acid are sensitive to sialidases. Resistance of Neu5Gc-containing polySia to sialidases provides a potential explanation for the rarity of Neu5Gc in the vertebrate brain.
    MeSH term(s) Amino Sugars/chemistry ; Amino Sugars/metabolism ; Animals ; Bacteria/chemistry ; Bacteria/metabolism ; Brain/metabolism ; Brain Chemistry/physiology ; Carbohydrate Conformation ; Cattle ; Dolphins ; Elephants ; Evolution, Molecular ; Hydrolysis ; Mice ; N-Acetylneuraminic Acid ; Nerve Tissue Proteins/chemistry ; Nerve Tissue Proteins/metabolism ; Neuraminic Acids/chemistry ; Neuraminic Acids/metabolism ; Neuraminidase/chemistry ; Neuraminidase/metabolism ; Pan troglodytes ; Rats ; Species Specificity ; Swine
    Chemical Substances Amino Sugars ; Nerve Tissue Proteins ; Neuraminic Acids ; N-glycolylneuraminic acid (1113-83-3) ; Neuraminidase (EC 3.2.1.18) ; N-Acetylneuraminic Acid (GZP2782OP0)
    Language English
    Publishing date 2012-06-12
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.M112.365056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Salivary Gland Tumors in Iran: A Systematic Review of 2870 Cases Based on the New WHO Classification.

    Assar, Sahar / Assar, Sepideh / Mardanifard, Heidar-Ali / Jaafari-Ashkavandi, Zohreh

    Iranian journal of pathology

    2023  Volume 18, Issue 1, Page(s) 1–11

    Abstract: ... calculated as prevalence (%) * (N/the sum of all N). We used the unpaired Two-sample T-test to compare ...

    Abstract Background & objective: There is no consensus on the prevalence of salivary gland tumors (SGTs) in Iran. Thus, we systematically reviewed the literature about the prevalence of SGTs in Iran and applied the last world health organization (WHO) classification.
    Methods: The systematic literature search was performed in EMBASE, Scopus, PubMed MEDLINE, Google Scholar, Scientific Information Database (SID), and Magiran; we searched for "salivary gland," "tumor," "prevalence," and "Iran" until 1 March 2021. The studies included were written in the English and Farsi languages. The weighted mean prevalence of SGTs was calculated as prevalence (%) * (N/the sum of all N). We used the unpaired Two-sample T-test to compare the weighted means.
    Results: A total of 17 studies, including 2870 patients, were selected for the data synthesis. The weighted mean prevalence of benign and malignant tumors was 66% (95% CI: 59-73) and 34% (95% CI: 27-41), respectively. The patients' mean age was reported in 10 out of the 17 studies. The weighted mean age of the patients was 40 (95% CI: 37-42) and 49 (95% CI: 43-55) years for benign and malignant tumors, respectively (
    Conclusion: More than one-third of SGTs in Iran were malignant, which is higher than the reports from Middle Eastern countries. Information about risk factors and the burden of SGTs in Iran is insufficient. Thus, further well-designed longitudinal studies are warranted.
    Language English
    Publishing date 2023-03-23
    Publishing country Iran
    Document type Journal Article ; Review
    ZDB-ID 2478278-6
    ISSN 1735-5303 ; 2345-3656
    ISSN 1735-5303 ; 2345-3656
    DOI 10.30699/IJP.2023.559121.2942
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Formation of N(epsilon)-(carboxymethyl)lysine and loss of lysine in casein glucose-fatty acid model systems.

    Lima, Maria / Assar, Shima H / Ames, Jennifer M

    Journal of agricultural and food chemistry

    2010  Volume 58, Issue 3, Page(s) 1954–1958

    Abstract: ... when proteins are heated with reducing sugar or lipid. N(epsilon)-(Carboxymethyl)lysine (CML) is the most ...

    Abstract Advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs) form when proteins are heated with reducing sugar or lipid. N(epsilon)-(Carboxymethyl)lysine (CML) is the most commonly studied AGE/ALE in foods, but the relative importance of dietary sugar and lipid as its precursors is uncertain. The aim of this study was to determine the relative amounts of CML formed from fatty acid and glucose in a model food system. Model systems were prepared by heating casein (3.2%) with glucose or fatty acid (oleic, linoleic, linolenic, or arachidonic acid) (200 mM) or a mixture of glucose and linolenic acid (200 mM of each precursor) at 95 degrees C for up to 8 h. CML was determined by ultrapressure liquid chromatography-tandem mass spectrometry. The amount of CML formed from casein and glucose incubated at 95 degrees C for 8 h was 15-fold higher than that obtained when casein was heated with arachidonic acid under the same conditions. However, the loss of lysine in the casein-arachidonic acid incubations was 83% compared to 54% loss in the casein-glucose incubations. The loss of lysine in casein-fatty acid model systems increased with degree of unsaturation of the fatty acid. The formation of lipid peroxidation products during oxidation of fatty acids might be a potent factor for loss of lysine in the casein-fatty acid systems.
    MeSH term(s) Animals ; Caseins/chemistry ; Cattle ; Fatty Acids/chemistry ; Glucose/chemistry ; Lysine/analogs & derivatives ; Lysine/chemistry ; Models, Chemical
    Chemical Substances Caseins ; Fatty Acids ; N(6)-carboxymethyllysine (70YDX3Z2O7) ; Glucose (IY9XDZ35W2) ; Lysine (K3Z4F929H6)
    Language English
    Publishing date 2010-02-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 241619-0
    ISSN 1520-5118 ; 0021-8561
    ISSN (online) 1520-5118
    ISSN 0021-8561
    DOI 10.1021/jf903562c
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Hemophagocytic lymphohistiocytosis accompanying Still's disease: A case report.

    Ahmadzadeh, Arman / Babadi, Neda / Farsad, Faraneh / Babadi, Saba / Assar, Shirin

    Clinical case reports

    2023  Volume 11, Issue 10, Page(s) e7955

    Abstract: Hemophagocytic lymphohistiocytosis (HLH) is a rare hematologic disease that occurs due to immune system dysfunction. Clinical manifestations of this disease are fever, increased ferritin level, cytopenia, and hemophagocytosis in the biopsy report of the ... ...

    Abstract Hemophagocytic lymphohistiocytosis (HLH) is a rare hematologic disease that occurs due to immune system dysfunction. Clinical manifestations of this disease are fever, increased ferritin level, cytopenia, and hemophagocytosis in the biopsy report of the bone marrow. We report a 36-year-old woman referred to our hospital with persistent fever, arthralgia in interphalangeal joints, and cutaneous rash on the trunk, was subsequently diagnosed as an adult-onset Still's disease (AOSD), and after bone marrow aspiration, HLH was diagnosed with her.
    Language English
    Publishing date 2023-10-10
    Publishing country England
    Document type Case Reports
    ZDB-ID 2740234-4
    ISSN 2050-0904
    ISSN 2050-0904
    DOI 10.1002/ccr3.7955
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Audio / Video: Formation of N(epsilon)-(Carboxymethyl)lysine and Loss of Lysine in Casein Glucose−Fatty Acid Model Systems

    Lima, Maria / Assar, Shima H / Ames, Jennifer M

    Journal of agricultural and food chemistry. 2010 Feb. 10, v. 58, no. 3

    2010  

    Abstract: Advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs) form when proteins are heated with reducing sugar or lipid. Nε-(Carboxymethyl)lysine (CML) is the most commonly studied AGE/ALE in foods, but the relative importance of ... ...

    Abstract Advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs) form when proteins are heated with reducing sugar or lipid. Nε-(Carboxymethyl)lysine (CML) is the most commonly studied AGE/ALE in foods, but the relative importance of dietary sugar and lipid as its precursors is uncertain. The aim of this study was to determine the relative amounts of CML formed from fatty acid and glucose in a model food system. Model systems were prepared by heating casein (3.2%) with glucose or fatty acid (oleic, linoleic, linolenic, or arachidonic acid) (200 mM) or a mixture of glucose and linolenic acid (200 mM of each precursor) at 95 °C for up to 8 h. CML was determined by ultrapressure liquid chromatography−tandem mass spectrometry. The amount of CML formed from casein and glucose incubated at 95 °C for 8 h was 15-fold higher than that obtained when casein was heated with arachidonic acid under the same conditions. However, the loss of lysine in the casein−arachidonic acid incubations was 83% compared to 54% loss in the casein−glucose incubations. The loss of lysine in casein−fatty acid model systems increased with degree of unsaturation of the fatty acid. The formation of lipid peroxidation products during oxidation of fatty acids might be a potent factor for loss of lysine in the casein−fatty acid systems.
    Keywords glycation ; lysine ; casein ; fatty acids ; model food systems ; Maillard reaction ; heat treatment ; food analysis ; food composition
    Language English
    Dates of publication 2010-0210
    Size p. 1954–1958.
    Document type Article ; Audio / Video
    ZDB-ID 241619-0
    ISSN 1520-5118 ; 0021-8561
    ISSN (online) 1520-5118
    ISSN 0021-8561
    DOI 10.1021/jf903562c
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article: Determination of N ε-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry

    Assar, Shima H / Moloney, Catherine / Lima, Maria / Magee, Ronald / Ames, Jennifer M

    Amino acids. 2009 Feb., v. 36, no. 2

    2009  

    Abstract: ... spectrometer operated in multiple reaction monitoring mode to determine the advanced glycation endproduct, N ε ...

    Abstract We report the use of ultra pressure liquid chromatography (UPLC), coupled to a tandem mass spectrometer operated in multiple reaction monitoring mode to determine the advanced glycation endproduct, N ε-(carboxymethyl)lysine (CML). The procedure was applied to acid hydrolyzates of protein isolated from a range of foods (milks processed at different temperatures, butter, cheese, infant formulae, bread, raw and cooked minced beef and olive oil). Highest levels of CML were determined in white bread crust (15.2 ± 0.63 mmol/mol Lys), wholemeal bread crust (13.1 ± 0.61 mmol/mol Lys) and evaporated full-fat milk (4.86 ± 0.77 mmol/mol Lys). Lowest levels of CML were measured in raw minced beef beef (0.03 ± 002 mmol/mol Lys), raw full-fat cow's milk (0.08 ± 0.03 mmol/mol Lys) and pasteurized skimmed cow's milk (0.09 ± 0.002 mmol/mol Lys). CML could not be detected in olive oil.
    Language English
    Dates of publication 2009-02
    Size p. 317-326.
    Publisher Springer Vienna
    Publishing place Vienna
    Document type Article
    ZDB-ID 1121341-3
    ISSN 1438-2199 ; 0939-4451
    ISSN (online) 1438-2199
    ISSN 0939-4451
    DOI 10.1007/s00726-008-0071-4
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Medical treatment of small abdominal aortic aneurysm.

    Assar, A N

    The Journal of cardiovascular surgery

    2012  Volume 53, Issue 4, Page(s) 517–525

    Abstract: Conventional open repair or endovascular aneurysm repair is indicated for infrarenal abdominal aortic aneurysm (AAA) when the diameter of the latter is ≥ 5.5 cm. This therapeutic strategy is based on results of randomized trials of open repair versus ... ...

    Abstract Conventional open repair or endovascular aneurysm repair is indicated for infrarenal abdominal aortic aneurysm (AAA) when the diameter of the latter is ≥ 5.5 cm. This therapeutic strategy is based on results of randomized trials of open repair versus ultrasound surveillance of small AAA (<5.5 cm). Studies of screening for AAA have shown that >90% of aneurysms detected are small aneurysms (<5.5 cm). Despite the low annual risk of rupture of these aneurysms, patients with small AAA are left with a potentially life-threatening disease for which no immediate treatment is available. Hence, medical treatment directed at limiting the expansion of small AAA has emerged as an alternative therapeutic strategy. Randomized trials of doxycycline, roxithromycin, and propranolol in patients with small AAA have been published. The results of the doxycycline and roxithromycin trials suggest that both medications can limit AAA expansion, especially during the first year of treatment. Propranolol did not limit AAA expansion, and the trials were stopped because of its serious side effects. In other studies, statins and indomethacin have also been shown to limit AAA expansion. However, these studies were observational with relatively small numbers of patients. Thus, large randomized controlled trials with long follow-up are needed to objectively assess the efficacy of medications that have shown potential in limiting AAA expansion. In addition, recent evidence of regression of AAA in experimental animal models is likely to change our concepts of the molecular pathogenesis of AAA, and could make medical treatment of small AAA a possibility.
    MeSH term(s) Aortic Aneurysm, Abdominal/diagnosis ; Aortic Aneurysm, Abdominal/drug therapy ; Aortic Aneurysm, Abdominal/etiology ; Cardiovascular Agents/adverse effects ; Cardiovascular Agents/therapeutic use ; Disease Progression ; Doxycycline/therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Indomethacin/therapeutic use ; Propranolol/adverse effects ; Risk Factors ; Risk Reduction Behavior ; Roxithromycin/therapeutic use ; Time Factors ; Treatment Outcome
    Chemical Substances Cardiovascular Agents ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Roxithromycin (21KOF230FA) ; Propranolol (9Y8NXQ24VQ) ; Doxycycline (N12000U13O) ; Indomethacin (XXE1CET956)
    Language English
    Publishing date 2012-08
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 80143-4
    ISSN 1827-191X ; 0021-9509
    ISSN (online) 1827-191X
    ISSN 0021-9509
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Clonal mesenchymal stem cell-derived extracellular vesicles improve mouse model of weight drop-induced traumatic brain injury through reducing cistauosis and apoptosis.

    Amini, Azadeh / Shekari, Faezeh / Assar Kashani, Sara / Eslami, Nasim / Nazari, Abdoreza / Tofigh, Nahid / Shahpasand, Koorosh / Akbari Javar, Hamid / Baharvand, Hossein

    Experimental neurology

    2023  Volume 367, Page(s) 114467

    Abstract: Objective: Traumatic brain injury (TBI) is a major risk factor for disabilities globally with no effective treatment thus far. Recently, homogenous population of clonal mesenchymal stem cells (cMSC) and their derived extracellular vesicles (cMSC-EVs) ... ...

    Abstract Objective: Traumatic brain injury (TBI) is a major risk factor for disabilities globally with no effective treatment thus far. Recently, homogenous population of clonal mesenchymal stem cells (cMSC) and their derived extracellular vesicles (cMSC-EVs) have been proposed as a promising TBI treatment strategy. We herein investigated possible therapeutic effect of cMSC-EVs in TBI treatment and the underlying mechanisms considering cis p-tau as an early hallmark of TBI.
    Methods: We examined the EVs morphology, size distribution, marker expression, and uptake. Moreover, the EVs neuroprotective effects were studied in both in-vitro and in-vivo model. We also examined the anti-cis p-tau antibody-loading characteristics of the EVs. We treated TBI mouse model with EVs; prepared from cMSC-conditioned media. TBI mice were given cMSC-EVs intravenously and their cognitive functions were analyzed two months of the treatment. We employed immunoblot analysis to study the underlying molecular mechanisms.
    Results: We observed a profound cMSC-EVs uptake by primary cultured neurons. We found a remarkable neuroprotective effect of cMSC-EVs upon nutritional deprivation stress. Furthermore, cMSC-EVs were effectively loaded with an anti-cis p-tau antibody. There was a significant improvement in cognitive function in TBI animal models treated with cMSC-EVs compared to the saline-treated group. There was a decreased cis p-tau and cleaved caspase3 as well as increased p-PI3K in all treated animals.
    Conclusions: The results revealed that cMSC-EVs efficiently improved animal behaviors after TBI by reducing cistauosis and apoptosis. Moreover, the EVs can be employed as an effective strategy for antibody delivery during passive immunotherapy.
    MeSH term(s) Mice ; Animals ; Brain Injuries, Traumatic/complications ; Brain Injuries, Traumatic/metabolism ; Mesenchymal Stem Cells/metabolism ; Disease Models, Animal ; Extracellular Vesicles ; Apoptosis
    Language English
    Publishing date 2023-06-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 207148-4
    ISSN 1090-2430 ; 0014-4886
    ISSN (online) 1090-2430
    ISSN 0014-4886
    DOI 10.1016/j.expneurol.2023.114467
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.

    Karamali, Negin / Mahmoudi, Zahra / Roghani, Seyed Askar / Assar, Shirin / Pournazari, Mehran / Soufivand, Parviz / Karaji, Ali Gorgin / Rezaiemanesh, Alireza

    Clinical rheumatology

    2023  Volume 43, Issue 1, Page(s) 147–157

    Abstract: Purpose: SYVN1 is an endoplasmic reticulum (ER)-resident E3 ubiquitin ligase that has an essential function along with SEL1L in rheumatoid arthritis (RA) pathogenesis. This study aimed to investigate the changes in the expression of peripheral blood ... ...

    Abstract Purpose: SYVN1 is an endoplasmic reticulum (ER)-resident E3 ubiquitin ligase that has an essential function along with SEL1L in rheumatoid arthritis (RA) pathogenesis. This study aimed to investigate the changes in the expression of peripheral blood ncRNAs and SYVN1-SEL1L affected by DMARDs treatment.
    Methods: Twenty-five newly diagnosed RA patients were randomly assigned to receive conventional DMARDs (csDMARDs) and methylprednisolone for six months. The peripheral blood gene expression of SYVN1 and SEL1L and possible regulatory axes, NEAT1, miR-125a-5p, and miR-19b-3p, were evaluated before and after qRT-PCR. We also compared differences between the patients and healthy controls (HCs), and statistical analyses were performed to determine the correlation between ncRNAs with SYVN1-SEL1L and the clinical parameters of RA.
    Results: Expression of NEAT1 (P = 0.0001), miR-19b-3p (P = 0.007), miR-125a-5p (P = 0.005), and SYVN1 (P = 0.036) was significantly increased in newly diagnosed patients compared to HCs; also, miR-125a-5p, miR-19b-3p, and SYVN1 were significantly overexpressed after treatment (P = 0.001, P = 0.001, and P = 0.005, respectively). NEAT1 was positively correlated with SYVN1, and miR-125a-5p had a negative correlation with anti-cyclic citrullinated peptides. The ROC curve analysis showed the potential role of selected ncRNAs in RA pathogenesis.
    Conclusion: The results indicate the ineffectiveness of the csDMARDs in reducing SYVN1 expression. The difference in expression of ncRNAs might be useful markers for monitoring disease activity and determining therapeutic responses in RA patients. Key Points • The expression of NEAT1 is significantly upregulated in RA patients compared to HC subjects. • miR-19b-3p, miR-125a-5p, and SYVN1 are significantly upregulated in RA patients compared to HC subjects. • The expression of miR-19b-3p and miR-125a-5p is significantly increased in RA patients after treatment with DMARDs and methylprednisolone. • NEAT1 is positively correlated with SYVN1.
    MeSH term(s) Humans ; Methylprednisolone/therapeutic use ; MicroRNAs/metabolism ; Arthritis, Rheumatoid/drug therapy ; Arthritis, Rheumatoid/genetics ; Polymerase Chain Reaction ; Antirheumatic Agents/therapeutic use ; Proteins/genetics ; Proteins/therapeutic use
    Chemical Substances Methylprednisolone (X4W7ZR7023) ; MicroRNAs ; Antirheumatic Agents ; SEL1L protein, human ; Proteins
    Language English
    Publishing date 2023-12-04
    Publishing country Germany
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-023-06808-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top